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Abstract: Bone Marrow mesenchymal stem cells can be
induced to differentiate into osteoblasts to regenerate dam-
aged bone tissue using tissue engineering techniques. In
this study, we examine the use of chitosan scaffolds with
double pore structure prepared by an innovative method
that combines freeze gelation (that produces micropores)
and particle leaching out technique (that produces intercon-
nected spherical macropores) seeking to enhance the osteo-
genic differentiation of goat bone marrow stromal cells
(GBMSCs). The double pore architecture of the scaffold was
characterized by scanning electron microscopy (SEM),
microcomputed tomography and confocal laser scanning
microscopy. The obtained hierarchical pore structure allowed
very efﬁcient seeding of GBMSCs that are able to occupy
the whole volume of the scaffold, showing good adhesion
and proliferation. GBMSCs were differentiated into osteo-
blasts as indicated by alkaline phosphatase activity and
osteocalcin expression. The results of this study demonstrate
that chitosan scaffold may be promising biomaterial for
bone regeneration. VC 2010 Wiley Periodicals, Inc. J Biomed Mater
Res Part A: 95A: 1182–1193, 2010.
Key Words: chitosan, macroporous scaffolds, mesenchymal
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INTRODUCTION
Current bone tissue engineering strategies are focused on
the restoration of damaged tissue architecture by transplan-
tation of cells in combination with a suitable three-dimen-
sional scaffold.1 Mesenchymal stem cells (MSCs) presenting
in bone marrow have a high ability to renew and differenti-
ate themselves into various lineages of conjunctive cells
including osteoblasts2,3 as bone progenitors cells.4,5 MSCs
can be seeded into three-dimensional scaffolds and differen-
tiated to form tissue-engineered construct6 under appropri-
ate culture conditions.
A number of biodegradable materials including syn-
thetic7–9 and natural10–12 polymers have been exhaustively
explored as supportive scaffolds for bone tissue engineering
applications. Among them, naturally derived polymers are of
special interest due to, as natural components of living
structures, their biological and chemical similarities to natu-
ral tissues.13 Chitosan (CHT) is a biocompatible and biode-
gradable polysaccharide; its degradation products, CHT oli-
gosaccharides, are also biocompatible. In addition, CHT can
be processed into interconnected porous structure by
freeze–drying, freeze-gelation, and other techniques.14,15
The interconnected porous structure is a promising charac-
teristic for cell colonization rate, nutrient perfusion, and
functionality of the tissue-engineered construct.16–18 Poros-
ity, pore interconnectivity, pore architecture, that is, pore
shape, size, distribution, and orientation also affect the me-
chanical properties and degradation rate of the scaffolds.
Madihally and Mattew15 studied the inﬂuence of porous
structure on tensile testing of hydrated porous and nonpo-
rous membranes. The results obtained reveal that elastic
moduli of porous membrane are 10-fold lower than those of
nonporous membrane.
Enzymatic degradation of CHT porous materials depends
greatly on CHT characteristics (molecular weight, deacetyla-
tion degree, etc.) but also on porosity and interconnected
Correspondence to: D. M. Garcı´a Cruz; e-mail: dugarcru@ter.upv.es
Contract grant sponsor: Spanish Ministry of Education (including the FEDER ﬁnancial support); contract grant number: MAT2007-66759-C03-01
Contract grant sponsor: Science and Innovation Ministry; contract grant number: PTA2008-0943-P
Contract grant sponsor: Generalitat Valenciana (Grups d’investigacio´ Emergents); contract grant number: GV/2009/126
Contract grant sponsors: VI National R&D&i Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions, Instituto de Salud
Carlos III (European Regional Development Fund)
Contract grant sponsor: FCT project; contract grant number: PTDC/QUI/68804/2006
1182 VC 2010 WILEY PERIODICALS, INC.
porous structure because the degradation medium diffusion
is favored in highly porous materials. On the other hand,
the biodegradation rate plays a crucial role on the long-
term applications of cell/scaffold construct because it affects
many cellular processes including cell growth and regenera-
tion of tissue.
CHT-based materials have been used in bone tissue engi-
neering as it was shown that they promote growth and min-
eral rich matrix deposition by osteoblasts in culture.19–24
However, CHT-based scaffolds have been usually processed
using single techniques that induce structures exhibiting fre-
quently pores with sizes of the same range and with limited
interconnectivity. The combination of different processing
methodologies could be a strategy to obtain more complex
and interconnected structures.25–28
Many studies focused in a combination of CHT with
other polymer or inorganic materials to enhance the me-
chanical properties and bioactivity. In this work, CHT scaf-
folds with a controlled porous structure, including micro
and macropores, were designed by a new fabrication
method based in the combination of both freeze-gelation
and leaching out techniques. This methodology can be used
to generate scaffolds with morphological and mechanical
properties more selectively designed to meet the speciﬁcity
of bone-repair needs. In this study, the morphology, micro-
architecture of the interconnected porous structure of CHT
scaffold was assessed and the biological response of the ma-
terial was investigated by the osteogenic differentiation of
MSCs isolated from goat bone marrow.
EXPERIMENTAL PART
Materials
CHT derived from crab shells was purchased from Sigma
Aldrich (practical grade, Cat. No: 417963, Madrid, Spain)
with deacetylation degree of 75% determined by ﬁrst deriv-
ative UV spectrophotometry.29 Viscosity-average molecular
weight of 1.5  106 g/mol was determined by Mark-Hou-
wink equation using 0.1M CH3COOH/0.2M NaCl as a solvent
system at 25C. Poly(ethyl methacrylate) microspheres with
molecular weight of 50  103 g/mol and average micro-
sphere diameter of 200 lm, used as porogen, were supplied
by Lucite International (Tennessee, USA). Lysozyme from
hen egg-white, sodium azide, and phosphate-buffered solu-
tion (PBS, pH 7.4) were supplied from Sigma-Aldrich. So-
dium hydroxide (NaOH), absolute ethanol, acetic acid (HPLC
grade), and other reagents were obtained from Scharlau
(Valencia, Spain) and used without further puriﬁcation. For
cell culture studies, a-minimum essential medium (a-MEM),
sodium b-glycerophosphate, ascorbic acid, and dexametha-
sone were purchased from Sigma Aldrich (Madrid, Spain),
and foetal bovine serum (FBS), penicillin–streptomycin–
amphotericin and trypsin- EDTA solution were obtained
from GIBCOVR .
Preparation of CHT scaffolds
CHT scaffolds were prepared by a combination of freeze ge-
lation and leaching out technique of poly(ethyl methacry-
late) microspheres, used as porogen. CHT solutions with
concentration of 4 wt % were prepared by dissolution of
CHT ﬂakes in 0.1M acetic acid. CHT solutions were poured
into a cylindrical mold, mixed with 70 wt % of PEMA micro-
spheres and frozen in liquid nitrogen (196C). Then, they
were soaked into a sodium hydroxide and ethanol mixture
at 20C for 3 days. Afterward, the scaffolds were washed
with distilled water until pH 7 to remove the excess of
NaOH and the porogen microspheres were removed by
soxhlet extraction using absolute ethanol as a solvent during
3 days. Finally, the porous samples were transferred into
freeze-drier (Telstar) and lyophilized at 80C for 3 days to
ensure that they were completely dried. The size of scaf-
folds used for cell culture was 7 mm of diameter and 3 mm
of thickness.
Morphological analysis, architecture, and
interconnectivity of CHT scaffolds
Morphological analysis of CHT scaffolds were examined in a
scanning electron Jeol JSM-5410, SEM, microscope. All speci-
mens were coated with a conductive layer of sputtered gold.
The micrographs were taken at an accelerating voltage of
20 kV in order to ensure a suitable image resolution. The
architecture and interconnectivity of porous materials were
performed by microcomputed tomography (l-CT) imaging
using a SkyScan1072 system (Kontuch, Belgium) with pene-
trative X-rays of 50 keV. The X-ray scans were acquired in
high-resolution mode. Mimicss software (Materialise, Bel-
gium) was used to visualize the 2D X-ray sections images of
the materials layered scaffolds. From the l-CT data set, 200
slice of a region of interest were used to investigate the
continuity of the porous materials.
Pore size characterization using image analysis
An in-house software, called ESTRA,30 was developed using
MATLAB R2007a (The Mathworks, Inc., Natick, MA) to char-
acterize 3D structures through image analysis. The l-CT
images were processed as a series of 200 slices of 1024 
1024 pixels with a spatial resolution of 7.13 lm. Before
performing a structural and mechanical analysis to the l-CT
images, a preprocessing consisting of segmentation and
binarization steps was performed in order to reduce compu-
tational burden.
For segmentation, a squared region of interest (ROI) of
400 pixels edge was selected in each slice by an automated
algorithm in order to process a representative sample of the
scaffold. Resultant grayscale images were stored in a three-
dimensional matrix representing a 3D reconstruction of the
speciﬁed volume of interest (VOI) of the scaffold, consider-
ing isotropic voxels.
Afterwards, images were converted to its binarized ver-
sion in order to discriminate structure voxels from empty
voxels. The optimum threshold value applied during binar-
ization was calculated for each slice using Otsu’s method.31
Binarized images were stored in a 3D binary matrix com-
pounding a logical representation of the VOI.
Measurement of structure separation or mean pore size
was assessed by a 3D algorithm. The method consisted of a
structural voxel by voxel inspection. That is, in a given voxel
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corresponding to a pore (black voxel), number of contiguous
voxels on X direction are ﬁrst counted, then the same is
done for Y, and ﬁnally for Z. Then, if we average the contig-
uous voxels in the three directions, we obtain the mean
local pore size. Repeating this process for all pore voxels,
mean pore size as well as pore size distributions were
obtained. These histograms have been gracefully used to
assess the effectiveness of the scaffold manufacture process.
In vitro degradation
The in vitro degradation of CHT scaffolds was followed in
5 mL of PBS containing 10 lg/mL lysozyme and 0.02 wt %
of sodium azide at 37C. The concentration of lysozyme was
chosen to correspond to the concentration in human se-
rum.32–34 Brieﬂy, CHT scaffolds of known dry weight were
incubated in the lysozyme solution and placed into the
water bath with orbital shaker (Unitronic OR, Selecta) at
50 rpm for the period of study. The lysozyme solution was
refreshed every 3 days to guarantee continuous enzyme ac-
tivity. After 7, 14, 35, and 45 days, samples were removed
from the medium, rinsed in distilled water, and dehydrated
with solutions of increasing contents of ethanol up to con-
stant weight. The extent of in vitro degradation was
expressed as percentage of weight loss of the dried scaffolds
after lysozyme treatment.
Isolation and culture of goat bone marrow stromal cells
(GBMSCs)
Bone marrow stromal cells were isolated from the iliac crest
of adult goats and cultured with Dulbecco’s Modiﬁed Eagle’s
Medium (DMEM) supplemented with 10% fetal bovine se-
rum, (FBS; Gibco, UK) and antibiotic/antimycotic (1% A/B,
Gibco, UK) solution containing 10,000 units/mL penicillin
G sodium, 10,000 mg/mL streptomycin sulphate and
25 mg/mL amphotericin B as FungizonesVR in 0.85 vol %
saline until conﬂuence and subcultured at passage 1 or 2
before seeding.
GBMSCs cultured into porous CHT scaffolds and cell
differentiation
CHT scaffolds prepared as described above were sterilized
by ethylene oxide under conditions previously described35
and immersed in a-MEM for 24 h prior to cell seeding.
GBMSCs cells were enzymatically lifted with 3 mL of
trypsin after reaching 80% of conﬂuence and a cell suspen-
sion at a cellular density of 1  105cells/scaffolds was
injected into the CHT scaffolds and then incubated at 37C
under 5% of CO2 conditions for 1 h. After this time, 800 lL
of fresh medium was added to each well. For inducing
osteogenic differentiation, cells/scaffolds constructs were
cultured in 48-well plates for 3 days, 1, 2, 3, and 4 weeks
with osteogenic differentiation media consisting of a-MEM
supplemented with osteogenic supplements namely, 108M
dexamethasone, 50 mg/mL ascorbic acid, and 10 mM b-
glycerophosphate. Osteogenic medium was renewed every 3
days. Each experiment was conducted in triplicate. Porous
materials without cells processed and cultured under the
same conditions were used as reference.
Cell viability assay
The viability of GBMSCs cultured for 3 days, 1, 2, 3, and 4
weeks onto the CHT scaffolds was determined using MTS 3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium) assay following manufacturer
instructions (Promega). The assay is based on the mitochon-
drial activity of living cells. MTS tetrazolium compound is
bioreducted by cells into a colored formazan product that is
soluble in tissue culture medium. This conversion is pre-
sumably accomplished by NADPH or NADH produced by de-
hydrogenase enzymes in metabolically active cells. The
quantity of formazan product is directly proportional to the
number of living cells in culture. The samples were washed
twice with PBS and incubated with fresh culture medium
without phenol red and FBS containing MTS reagent (ratio
5:1) at 37C for 3 h in darkness. After the incubation pe-
riod, the absorbance was quantiﬁed by photospectrometery
at 490 nm with a microplate reader (Bio-TeK, USA). The cor-
rect absorbance was calculated subtracting the sample ab-
sorbance of the controls (without cells).
Total DNA quantiﬁcation
The DNA content of GBMSCs cultured onto CHT scaffolds
was assessed at each incubation time (3 days, 1, 2, 3, and 4
weeks) using a ﬂuorimetric dsDNA quantiﬁcation kit (Pico-
Green, Molecular Probes). Samples were washed with PBS
and transferred into eppendorf tubes containing 1 mL of
sterile ultra-pure water and then stored in a 80C freezer
until assayed to ensure complete cell lysis. Prior to DNA
quantiﬁcation, scaffold cell constructs were thawed at room
temperature and sonicated for 15 min. Standards were pre-
pared as serial dilutions in ultra-pure water of a 100 lg/mL
DNA stock solution. Aqueous working solution of the
Quant-iTTM PicoGreenVR reagent was prepared as a ratio
1/200 in 1X TE buffer (10 mM Tris-HCl, 1 mM EDTA).
28.7 lL of samples and standards plus 71.3 lL of PicoGreen
solution and 100 lL of 1X TE buffer were added to individ-
ual wells of 96-well plate and incubated for 2 to 5 min at
room temperature, protected from the light prior to meas-
uring the ﬂuorescence using a microplate reader.
Evaluation of GBMSCs adhesion and morphology by SEM
Scaffold-cell constructs were washed twice with PBS and
ﬁxed with 2.5 v/v glutaraldehyde in PBS at 4C for 1 h.
Dehydration process was performed by sequential immer-
sion in serial diluted ethanol solutions (50, 60, 70, 80, 90,
TABLE I. Primary Antibodies Used for Immunoﬂuorescence
Assay
Primary Antibody Supplier
Antihuman collagen
type I
Rabbit,
polyclonal
Chemicon,
USA
Antihuman/mouse/rat
alkaline phosphatase
Mouse,
monoclonal
R&D Systems,
USA
Antihuman osteocalcin Mouse,
monoclonal
R&D Systems,
USA
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and 100% v/v) after that, the samples were air-dried at
room temperature overnight. Finally, scaffold-cell constructs
were sputter-coated with gold using a Fisons Instrument
Coater (Polaron SC 502, UK) with a current set at 18 mA,
for a coating time of 120 s and observed using a Leica
Cambridge S-360, UK scanning microscope.
Osteoblastic speciﬁc markers detection
Alkaline phosphatase activity by colorimetric analysis.
Alkaline phosphatase activity (ALP) was measured to evalu-
ate the osteoblastic differentiation. Cell lysates were incu-
bated in substrate solution (2 mM p-nitrophenyl phosphate
(pNp, Sigma), in a substrate buffer (1M diethanolamine at
pH 9.8) for 45 min in the dark at 37C. After the incubation
time, the reaction was stopped by adding 2M of sodium hy-
droxide and 0.2 mM EDTA and the product was quantiﬁed
at 405 nm using a set of pNp standards.
Von Kossa staining
von Kossa staining is a standard procedure for the detection
of mineralized tissue on different biomaterials. The cell-scaf-
fold constructs were ﬁxed in neutral buffered 10% formalin
3 weeks after osteogenic induction and 1 mm sections were
cut and stained. Scaffold sections were immersed in silver
nitrate solution (5 wt %) under UV light for 1 h. The silver
cation binds to anions, such as phosphates or carbonates,
and turns into black color. Digital images were taken using
an optical microscope (Nikon Eclipse E600).
Immunoﬂuorescence analysis
Type I collagen, alkaline phosphatase and osteocalcin (OC)
markers of osteoblastic differentiation were assessed by im-
munoﬂuorescence. To analyze the osteogenic differentiation
of the cells inside the scaffolds, the constructs were sec-
tioned in two slices (1 mm) and ﬁxed with formalin,
washed with PBS twice and permeabilized with 0.1 vol %
FIGURE 1. SEM microphotographs of surface (A) and cross-section view (B) of CHT scaffolds produced with 70 wt % PEMA microspheres used
as porogen. The inset in the surface image corresponds to a high magniﬁcation detail.
FIGURE 2. A cross-sectional lCT image (a) and 3D reconstruction (b) of a chitosan scaffold.
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Triton X-100 in PBS 1X and to block unspeciﬁc binding of
the antibodies, cell-scaffolds constructs were incubated with
10 vol % foetal bovine serum in PBS blocking solution for
2 h at room temperature. Afterwards, samples were incu-
bated in the diluted primary antibody solution (10 lg/mL)
(see Table I) overnight at 4C, samples were washed again
three times in PBS and then incubated with the respective
secondary ﬂuorochrome-conjugated antibody (Alexa 647)
for 2 h at room temperature in dark. Finally, samples were
washed three times with PBS before mounting the coverslip
with a drop of vectashield (Vector Laboratories) containing
DAPI to counterstain cell nuclei (blue). A Leica TCS SP2
AOBS (Leica Microsystems Heidelberg GmbH, Mannheim,
Germany) confocal laser scanning microscopy (CLSM) was
used. Two-dimensional pseudocolor images (255 grey lev-
els) were gathered with a size of 1024  1024 pixels.
To visualize type I collagen, the cell-scaffold constructs
were monitored in the confocal microscope, using a 20X
Plan-Apochromat Lambda Blue 0.70 IMM objective, with a
double excitation (405 and 633 nm) and a double emission
system (411–451 nm and 650–760 nm), with two multi-
pliers for blue and red ﬂuorescence. Double-labeled prepa-
ration was monitored in the confocal microscope, using a
40X Plan-Apochromat 1.25 N.A. oil objective, with a double
excitation (405 nm, 561 nm) and a double emission system
(411–451 nm, 571–664 nm), with two multipliers for blue
and red ﬂuorescence to determine ALP activity and OC.
Statistical analysis
Data were expressed as mean 6 standard deviation (SD). A one-
way Anova test was used to conduct statistical analysis, and sta-
tistical signiﬁcance was accepted at the probability level p< 0.05.
RESULTS
Morphology and characterization of CHT scaffolds
The methodology used in this study to prepare CHT scaf-
folds results in the formation of 3-D scaffolds with both
micro and macroporosity. Figure 1 shows the morphology
of the porous material examined by SEM. The surface image
FIGURE 3. Pore size distribution obtained by image analysis of the
lCT scans for CHT scaffold.
FIGURE 4. Weight loss of chitosan scaffold as a function of degrada-
tion time in PBS with 1 lg/ml of lysozyme. Data are shown as mean
6 standard deviation (n ¼ 3).
FIGURE 5. DNA content of GBMSCs cultured into CHT scaffolds. Data
show the average and its level of statistical signiﬁcance (p < 0.05).
The * indicates signiﬁcant differences.
FIGURE 6. GBMSCs viability into chitosan scaffolds after 3, 7, 14, 21,
and 28 days of culture. Data show the average and its level of statistical
signiﬁcance (p < 0.05). The * indicates signiﬁcant differences.
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of the material [Fig. 1(A) and inset] shows micro (pore size
around 10 lm) and macropores evenly distributed. The
cross-section view clearly shows the interconnectivity of the
macropores [Fig. 1(B)].
More insight in the pore connectivity can be obtained using
l-CT analysis that allows simultaneous evaluation of the three-
dimensional micropores structure and pore shape. Figure 2
shows a 2D cross-section slice of sequential scanning and a 3D
reconstruction of the full CHT scaffold from the l-CT slices.
The l-CT images show, in good agreement with SEM
cross-section pictures an interconnected highly porous
structure. Pore shape is almost spherical as expected, due
to the geometry of the porogen used. Average porosity of
the materials resulted in 84% 6 2%.
Pore size distribution was analyzed using ESTRA,30 an
in-house software, as a complementary technique. Figure 3
represents the pore size distribution of the scaffold. The
mean pore size is 140 lm, lower than the diameter of
PEMA microspheres used as porogen (200 lm). The reduc-
tion of the pore size can be a consequence of the dehydra-
tion characteristics of ethanol as a solvent, however, note
that the contraction of the pore size takes place isotropi-
cally. From Figure 3, it is not possible to distinguish the
double pore size as in SEM microphotographs.
Degradation studies
To mimic the biodegradation rate of CHT scaffolds in physi-
ological conditions,34 the degradation studies performed in
this work were carried out on PBS (pH 7.4, 37C) in pres-
ence of 10 lg/mL of lysozyme. The enzyme biodegrades the
polysaccharide by hydrolyzing the b 1,4 N-acetylglucos-
amine groups of CHT chains. Figure 4 shows the weight loss
proﬁle as a function of time. It was observed that the degra-
dation rates of CHT scaffolds increase as incubation time
increases; moreover a slight degradation after 45 days was
achieved, only 10 wt % of weight lose.
Culture of GBMSCs into CHT scaffolds
Cell viability, proliferation, and morphology. GBMSCs sus-
pension (50 lL) were seeded into the CHT scaffolds at a cel-
lular density of 1  105 cells/scaffold using a microsyringe
and incubated for 1 h to stimulate the cell adhesion to the
scaffold. After 1 h, the cell/scaffold construct was trans-
ferred to a new 48-well plate; to test only the cells attached
to the porous scaffolds, and 1 mL of fresh osteogenic me-
dium were added to each well.
The proliferation of GBMSCs evaluated after each incu-
bation time is shown in Figure 5. DNA content reveals a sig-
niﬁcant enhancement from day 3 to day 21, reaching a pla-
teau at this time point. The DNA analysis was corroborated
by MTS (Fig. 6) verifying that cells not only proliferate well
in CHT scaffolds but also were viable.
Figure 7 shows the morphological analysis of the surface
of the CHT scaffolds seeded with GBMSCs and cultured in
osteogenic medium at different culture times: 3, 7, 21, and
28 days. As can be seen, cells spread on the surface of the
scaffold and after 28 days culture the whole surface was
covered. To observe the cell morphology inside the micro
FIGURE 7. SEM microphotographs of CHT scaffolds surface cultured with GBMSCs.
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and macropores, the constructs were cross-sectioned in
thick slices and observed by SEM (Fig. 8).
The morphology of GBMSCs in the porous structure of
CHT scaffolds showed spreading cells with multiple ﬁlopo-
dia adhered to the scaffold wall, establishing bridges
between adjacent pores. The presence of extracellular ma-
trix (ECM), as a three-dimensional ﬁbril network, could al-
ready be detected after 14 days of culture. The observed
results suggest that the material system promoted intercel-
lular contacts and the spatial arrangement of the cells.
GBMSCs differentiation assessment by expression of
osteogenic speciﬁc marker
The expression of osteoblastic phenotype was assessed by
type I collagen, ALP activity and OC secretion. Cell-scaffold
constructs were cross-sectioned in thick slices ( 1 mm)
and observed with confocal microscopy. CLSM images
of GBMSCs cultured for 14 and 21 days are represented in
Figure 9. Nuclei were counterstained with DAPI (blue) and
the expression of osteoblastic-associated markers (type I
collagen, OC and ALP) were followed by alexa-647 (red)
linked to the secondary antibody.
Self-ﬂuorescence of CHT36 allows observing the micro
and macropore structure of the scaffold that is especially
clear in Figures 9(a) (in blue) and 10(b) (in violet due to
the superimposition of both ﬂuorescences: blue DAPI and
red alexa-647). These images conﬁrm the isotropic contrac-
tion of the scaffold during porogen extraction and pore con-
nectivity as previously accounted for by SEM and l-CT.
Numerous cells can be observed not only at the surface of
FIGURE 8. SEM microphotographs of cross-sections of scaffold-cells constructs at 14 days culture show morphology, adhesion, and extracellular
matrix production of GBMSCs into CHT scaffolds.
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the samples (Fig. 7), but also throughout the complete
cross-section of the scaffold. Cells are well distributed along
the interior of the scaffold localized mainly in the macro-
pores although some of them even penetrate into the
micropores. It is worth noting that good cell distribution
was obtained even if cell seeding was performed under
static conditions, without use of a bioreactor, which is
known to be an important tool in seeding cells into 3D
scaffolds.37–41
The expression of type I collagen was detected at 14
and 21 days respectively [Fig. 9(a,c)] thus showing the pro-
duction of collagenous matrix. ALP activity was assessed by
both colorimetric analysis and immunoﬂuorescence staining
(Fig. 10).
ALP activity of GBMSCs cultured into CHT scaffold in
osteogenic media increases along the ﬁrst two weeks (14
days) and then decreases [Fig. 10(a)]. Immunoﬂuorescence
of the cell/scaffold construct after 2 weeks of culture
revealed ALP expression [Fig. 10(b)]. Mineralized tissue in
CHT scaffolds were detected by von Kossa staining after 3
weeks of culture [Fig. 10(c)].
These results show an enhancement of the osteoblastic
phenotype expression levels. OC secretion by GBMSCs in
osteogenic media and mineralized tissue was detected from
day 21 respectively [Figs. 9(b,d) and 10(c)], which demon-
strate that osteoblastic differentiation was achieved in these
constructs.
DISCUSSION
The essential constituents for successful tissue engineering
include functionally active cells, biocompatible scaffolds for
in vitro differentiation/proliferation and subsequent implan-
tation into the defect site, and bioactive molecules stimulat-
ing differentiation such as growth factors.42 To facilitate cell
attachment and proliferation, high speciﬁc surface area and
interconnected pore structure are desirable. In this study,
CHT was selected as a biocompatible polymer to design a
potential substrate for bone regeneration due its promising
properties such as cell/tissue compatibility, biodegradability,
and functionality.43 The ability of CHT to support cell
attachment and proliferation is attributed to its chemical
properties and hydrophilic character.44,45 In orthopedic
applications, considerable attention have been given to CHT
based materials. Interesting characteristics that render CHT
suitable for this purpose are an intrinsic antibacterial nature
and the ability to be molded in 3D materials with highly po-
rous structure and interconnected pores with different
shapes and sizes under mild conditions, which facilitates
FIGURE 9. Immunoﬂuorescence analysis of type I collagen and osteocalcin by GBMSCs cultured at 14 and 21 days (a,c) into chitosan scaffolds
in osteogenic media. Osteocalcin expression was detected for 21 and 28 days (b,d). [Color ﬁgure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
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the osteoconductivity and enhance the bone formation both
in vitro and in vivo.40,46–48
In the study presented here, CHT scaffolds with a hier-
archical pore structure was obtained using an advanced
method that combines the techniques of freeze-gelation and
particulate leaching. The resulting scaffolds have an inter-
connected pore structure with small and large pores
(Fig. 1). Small pores are due to the freeze-gelation process
and result in a high surface area to allow cell attachment
and proliferation and to facilitate cell penetration into the
scaffold. On the other hand, large pores formed by the
leached out porogen facilitate cell growth and allow enough
volume to be ﬁlled in with cell-secreted extracellular matrix
that can thus create and organize their own three-dimen-
sional tissue like structures. Flow transport of nutrients and
metabolic waste is also facilitated by a high pore intercon-
nectivity. In previous works, Shin et al.27 studied the biolog-
ical response of porcine bone marrow derived MSCs on poly
(lactide-co-glycolide) scaffolds with interconnected pore
structure on two distinct lengths to bone tissue regenera-
tion. They obtained promising results on cell attachment,
proliferation and osteogenic differentiation. More recently,
some studies49–52 demonstrated the feasibility of CHT based
scaffolds for bone tissue engineering.
It has been shown that injection of a cell suspension in
the middle of the scaffold piece is a very effective cell seed-
ing procedure in this kind of material.53 Because of the high
pore interconnectivity; cells are forced to ﬂow through the
pore structure and adhere to the macropore walls. Although
the total volume of the cell suspension is only slightly larger
than the volume of the scaffold, a part of the cells leaves
the scaffold and ﬁnally can adhere on its surface or even on
the culture well. To ensure that cell culture initiates only
with the cells adhered to the scaffold, the samples were
moved to new wells after a short time. SEM microphoto-
graphs and immunoﬂuorescence show that a layer of cells
FIGURE 10. Expression of ALP activity assay of GBMSCs cultured into CHT scaffold was assessed by: (a) colorimetric analysis and (b) immuno-
ﬂuorescence staining. The ALP activity was detected at 14 days. Mineralization of CHT scaffolds were conﬁrmed by von Kossa staining (c).
[Color ﬁgure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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and extracellular matrix grows on the surface of the scaffold
while the pores of the scaffold are ﬁlled by cells as well.
DNA quantiﬁcation and MTS assay prove cell proliferation
and viability, although it is not possible to asses the differ-
ential proliferative capacity of cells situated on the scaffold
surface and thus behaving as in a monolayer culture and
those situated inside the pores with a three-dimensional
neighborhood, it is worth noting that cells can be observed
in the whole cross-section of the scaffold up to 28 days cul-
ture, this proves the good performance of the scaffold in
what respect to allow nutrients diffusion even if culture is
not performed in a bioreactor. The high porosity of the scaf-
fold and the particular pore architecture with high pore
interconnectivity seems to allow for cell viability at a dis-
tance up to 1.5 mm from the surface.
Another important characteristic of the scaffolds is their
biodegradability. Ideally scaffolds used in tissue engineering
are intended to degrade slowly after implantation and be
replaced by the new tissue.54 CHT has been shown to be
degraded mainly by lysozyme, which commonly exists in
various human body ﬂuids and tissues.32–34 Lysozyme could
hydrolyze the bindings between N-acetylmuramic acid and
N-acetylglucosamine in some bacteria’s cell wall. Therefore,
in this research, we utilized lysozyme as degradation
enzyme. The proﬁle of degradation of CHT scaffolds found
in our study can be explained due the lack of consecutive
N-acetylglucosamine residues, the CHT used in this study
has 85% deacetylation degree. The obtained results are in
agreement with the previous results reported in the litera-
ture in a number of studies.55–57
The development of osteoblastic-like cells from bone
marrow stromal precursors suggest the evolution of the
cells trough different developmental or maturational stages
that are revealed by changes in the levels of expression of
the known osteoblast-associated markers.58 Generally, osteo-
blast-differentiation takes places in three steps, which
include proliferation of cells, maturation and mineralization
of extracellular matrix. During proliferation, expression of
type I collagen is relatively high and then it decreases,59
whereas during maturation and synthesis of ECM, speciﬁc
osteoblast-phenotype markers such as ALP and OC are
expressed. Alkaline phosphatase increases but then
decreases when mineralization is well advanced60 while OC
appears approximately with mineralization.61,62
CHT scaffold with hierarchical pore structure allowed
the osteogenic differentiation of GBMSCs and their prolifera-
tion, which are related to the synthesis, deposition, and sub-
sequent mineralization of the collagenous extracellular
matrix.
CONCLUSIONS
GBMSCs seeded in CHT scaffolds with micro and macro-
pores are able to attach and gradually proliferate along 4
weeks of culture. SEM images showed that the substrate
surface becomes completely covered by a dense layer of
cells and viable cells are uniformly distributed in the pore
structure and a ﬁbrillar ECM production was detected.
GBMSCs expressed ALP, secreted OC and mineralized tissue
was observed, which conﬁrmed that the differentiation
along the osteoblastic lineage occurred.
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